LS
LLY icon

Leelyn Smith’s Eli Lilly LLY Stock Holding History

Leelyn Smith’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.89M Sell
7,410
-118
-2% -$121K 1.08% 20
2026
Q1 		$6.92M Sell
7,528
-24
-0.3% -$24.3K 0.97% 25
2025
Q4 		$8.12M Sell
7,552
-273
-3% -$261K 1.17% 17
2025
Q3 		$5.97M Buy
7,825
+388
+5% +$289K 0.9% 23
2025
Q2 		$5.8M Sell
7,437
-56
-0.7% -$43.5K 0.95% 23
2025
Q1 		$6.19M Sell
7,493
-303
-4% -$252K 1.1% 18
2024
Q4 		$6.02M Sell
7,796
-436
-5% -$361K 1.07% 17
2024
Q3 		$7.29M Sell
8,232
-377
-4% -$339K 1.32% 15
2024
Q2 		$7.79M Sell
8,609
-623
-7% -$498K 1.51% 11
2024
Q1 		$7.18M Sell
9,232
-728
-7% -$518K 1.44% 13
2023
Q4 		$5.81M Sell
9,960
-436
-4% -$254K 1.27% 15
2023
Q3 		$5.58M Sell
10,396
-1,722
-14% -$887K 1.36% 15
2023
Q2 		$5.68M Sell
12,118
-422
-3% -$177K 1.37% 16
2023
Q1 		$4.31M Buy
12,540
+396
+3% +$134K 1.1% 18
2022
Q4 		$4.44M Buy
12,144
+1,002
+9% +$355K 1.22% 18
2022
Q3 		$3.6M Sell
11,142
-2,425
-18% -$768K 1.24% 18
2022
Q2 		$4.4M Sell
13,567
-308
-2% -$92.5K 1.14% 27
2022
Q1 		$3.97M Buy
13,875
+764
+6% +$197K 1.04% 20
2021
Q4 		$3.62M Sell
13,111
-64
-0.5% -$16.2K 0.97% 22
2021
Q3 		$3.04M Buy
13,175
+396
+3% +$97.7K 0.88% 25
2021
Q2 		$2.93M Sell
12,779
-358
-3% -$71.9K 0.86% 27
2021
Q1 		$2.45M Buy
13,137
+1,019
+8% +$199K 0.73% 36
2020
Q4 		$2.03M Buy
12,118
+11,810
+3,834% +$1.76M 0.65% 40
2020
Q3 		$46K Hold
308
– – 0.02% 191
2020
Q2 		$51K Buy
308
+20
+7% +$3.07K 0.02% 200
2020
Q1 		$40K Sell
288
-3
-1% -$412 0.02% 175
2019
Q4 		$38 Buy
+291
New +$33.7K 0.02% 202

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Leelyn Smith's LLY Position: Q2 2026 in Review

Leelyn Smith reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $121K and leaving 7,410 shares worth $8.89M. The position accounts for 1.08% of the portfolio, ranked #20.

Leelyn Smith first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 2,299 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Leelyn Smith held 7,410 shares of Eli Lilly worth $8.89M as of Q2 2026.
  • Leelyn Smith sold 118 Eli Lilly shares in Q2 2026, an estimated $121K.
  • Eli Lilly made up 1.08% of Leelyn Smith's portfolio in Q2 2026, its #20 holding.
  • Leelyn Smith first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 2,299 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.